Subbu Nambi
Stock Analyst
(n/a)
# 970
Out of 4,648 analysts
19
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRAL GRAIL | Initiates: Neutral | n/a | $14.07 | - | 1 | Oct 17, 2024 | |
| VCYT Veracyte | Initiates: Buy | $40 | $34.47 | +16.04% | 1 | Oct 10, 2024 | |
| GH Guardant Health | Upgrades: Buy | $36 | $23.48 | +53.32% | 3 | Jun 28, 2024 | |
| SOPH SOPHiA GENETICS | Initiates: Buy | $6 | $3.54 | +69.49% | 1 | Jun 27, 2024 | |
| NAUT Nautilus Biotechnology | Initiates: Buy | $6 | $2.63 | +128.14% | 1 | Jun 27, 2024 | |
| TXG 10x Genomics | Downgrades: Neutral | n/a | $16.65 | - | 3 | Jun 26, 2024 | |
| RGEN Repligen | Initiates: Neutral | n/a | $138.41 | - | 1 | Jun 18, 2024 | |
| TWST Twist Bioscience | Initiates: Buy | $53 | $41.88 | +26.55% | 1 | Jun 5, 2024 | |
| CSTL Castle Biosciences | Initiates: Buy | $25 | $33.19 | -24.68% | 1 | Dec 14, 2023 | |
| MYGN Myriad Genetics | Initiates: Buy | $23 | $17.21 | +33.64% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $124.10 | -43.59% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $72.39 | +24.33% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.44 | - | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $155 | $154.22 | +0.51% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.70 | - | 1 | Dec 14, 2023 |
GRAIL
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $14.07
Upside: -
Veracyte
Oct 10, 2024
Initiates: Buy
Price Target: $40
Current: $34.47
Upside: +16.04%
Guardant Health
Jun 28, 2024
Upgrades: Buy
Price Target: $36
Current: $23.48
Upside: +53.32%
SOPHiA GENETICS
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $3.54
Upside: +69.49%
Nautilus Biotechnology
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $2.63
Upside: +128.14%
10x Genomics
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $16.65
Upside: -
Repligen
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $138.41
Upside: -
Twist Bioscience
Jun 5, 2024
Initiates: Buy
Price Target: $53
Current: $41.88
Upside: +26.55%
Castle Biosciences
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $33.19
Upside: -24.68%
Myriad Genetics
Dec 14, 2023
Initiates: Buy
Price Target: $23
Current: $17.21
Upside: +33.64%
Dec 14, 2023
Initiates: Buy
Price Target: $70
Current: $124.10
Upside: -43.59%
Dec 14, 2023
Initiates: Buy
Price Target: $90
Current: $72.39
Upside: +24.33%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $2.44
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $155
Current: $154.22
Upside: +0.51%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $2.70
Upside: -